Related Experiment Video
Updated: May 23, 2026

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Pathogenesis of vascular complications in Cushing's syndrome
Predrag Miljic1, Dragana Miljic, Joshua William Cain
1Clinic for Hematology, University Clinical Center, Faculty of Medicine, Belgrade University, Belgrade, Serbia.
Insights
Cushing's syndrome (CS) increases thrombosis risk due to hormonal imbalances affecting blood clotting. Further research is needed to prevent cardiovascular events in CS patients.
Area of Science:
- Endocrinology
- Hematology
- Cardiovascular Medicine
Background:
- Chronic high glucocorticoid levels in Cushing's syndrome (CS) are linked to hemostatic system alterations.
- CS patients exhibit increased atherothrombotic and venous thromboembolic events (VTE), leading to a five-fold higher mortality rate from cardiovascular complications.
- The precise mechanisms driving the prothrombotic state in CS remain incompletely understood.
Purpose of the Study:
- To investigate the prothrombotic state in Cushing's syndrome.
- To elucidate the underlying mechanisms contributing to hypercoagulability and thrombophilic phenotypes in CS.
- To identify potential strategies for preventing cardiovascular complications in CS patients.
Main Methods:
- Review of existing literature on hemostatic abnormalities in CS.
- Analysis of documented changes in coagulation factors (e.g., Factor VIII, von Willebrand factor).
- Consideration of the Virchow triad components (endothelial dysfunction, hypercoagulability, stasis) in CS pathogenesis.
Main Results:
- Elevated levels of Factor VIII and von Willebrand factor are frequently observed.
- Evidence suggests enhanced thrombin generation and reduced fibrinolytic activity.
- The contribution of these specific hemostatic changes to the overall prothrombotic phenotype requires further clarification.
Conclusions:
- Cushing's syndrome is associated with multiple hemostatic abnormalities contributing to a prothrombotic state.
- Endothelial dysfunction, hypercoagulability, and stasis likely play variable roles in CS-related thrombosis.
- Larger studies are necessary to develop effective prevention strategies for cardiovascular complications in CS.
Abstract:
Chronic exposure to high glucocorticoid levels in Cushing's syndrome (CS) is often associated with alterations in the hemostatic system and the expression of prothrombotic phenotypes. Increased frequency of both atherothrombotic and venous thromboembolic events (VTE) has been reported in patients with CS. In general, cardiovascular complications in these patients cause a five-fold increase in mortality compared to the normal population. Although numerous abnormalities in the hemostatic system have been detected in patients with CS, the underlying mechanisms of the prothrombotic state are not fully elucidated. High levels of factor VIII and von Willebrand factor, with evidence of enhanced thrombin generation and decreased fibrinolytic activity, have been documented in several studies. However, it is not clear to what extent these changes contribute to the shift of hemostatic balance towards the hypercoagulable state and expression of thrombophilic phenotypes. Thrombosis is usually a multicausal disease, and all three components of the so-called Virchow triad, namely 1) vascular abnormalities and endothelial dysfunction, 2) hypercoagulability and 3) stasis, may play a variable role in the pathogenesis of the prothrombotic state in CS patients. Larger studies are needed to establish strategies for prevention of cardiovascular complications in patients with Cushing's syndrome.
Related Concept Videos
Cushing Syndrome II: Pathophysiology
Cushing Syndrome I: Introduction
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Cytotoxic Edema: Pathophysiology
Venous Thrombosis I: Introduction
Peripheral Artery Disease I: Introduction
